Zhixiang Jian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhixiang Jian has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Haosheng Jin
Guangdong Acad Med Sci, Gen Surg Dept, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China
4 shared publications- Zi Yin
General Surgery Department of Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
4 shared publications Tingting Ma
Gynaecology and Obstetrics Department, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
3 shared publications- Baohua Hou
School of Medicine, Henan Polytechnic University, China
2 shared publications Min Yu
General Surgery Department of Guangdong General Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Rd, Guangzhou, 510080, China
2 shared publicationsYe Lin
General Surgery Department, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China [ protected
2 shared publications
Latest Publications
- 1 August 2018
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 56, 61-67
A meta-analysis of long-term survival outcomes between surgical resection and radiofrequency ablation in patients with single hepatocellular carcinoma ≤ 2 cm (BCLC very early stage)
The optimal management choice in consideration of long-term overall survival (OS) and disease-free survival (DFS) for patients with BLCL very early stage is a matter of debate. A systematic review and meta-analysis was conducted to evaluate the efficacy of liver resection (RES) and radiofrequency ablation (RFA) for single HCC 2 cm or less. The primary sources of the reviewed studies through December 2017, without restriction on the languages or regions, were Pubmed and Embase. The hazard ratio (HR) was used as a summary statistic for long-term outcomes. A total of 5 studies qualified for inclusion in this quantified meta-analysis with a total of 729 HCC patients of BCLC very early stage. Only postoperative 1-year OS was comparable in both RES and RFA groups. As for long-term outcomes of 3-year and 5-year OSs, RES was significantly better than RFA, the HRs were 0.64 (95%CI: 0.41, 1.00; P = 0.05) and 0.63 (95%CI: 0.42, 0.95; P = 0.03) respectively. In terms of postoperative DFS, reduced tumor recurrence was observed in RES, and all the short- and long-terms outcomes were favored RES. RES offers better long-term oncologic outcomes compared with RFA in current clinical evidences.
- 1 August 2018
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 56, 61-67
A meta-analysis of long-term survival outcomes between surgical resection and radiofrequency ablation in patients with single hepatocellular carcinoma ≤ 2 cm (BCLC very early stage)
The optimal management choice in consideration of long-term overall survival (OS) and disease-free survival (DFS) for patients with BLCL very early stage is a matter of debate. A systematic review and meta-analysis was conducted to evaluate the efficacy of liver resection (RES) and radiofrequency ablation (RFA) for single HCC 2 cm or less. The primary sources of the reviewed studies through December 2017, without restriction on the languages or regions, were Pubmed and Embase. The hazard ratio (HR) was used as a summary statistic for long-term outcomes. A total of 5 studies qualified for inclusion in this quantified meta-analysis with a total of 729 HCC patients of BCLC very early stage. Only postoperative 1-year OS was comparable in both RES and RFA groups. As for long-term outcomes of 3-year and 5-year OSs, RES was significantly better than RFA, the HRs were 0.64 (95%CI: 0.41, 1.00; P = 0.05) and 0.63 (95%CI: 0.42, 0.95; P = 0.03) respectively. In terms of postoperative DFS, reduced tumor recurrence was observed in RES, and all the short- and long-terms outcomes were favored RES. RES offers better long-term oncologic outcomes compared with RFA in current clinical evidences.
- 18 May 2018
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 22 (9) , 1565-1575
Revision of Surgical Margin under Frozen Section to Achieve R0 Status on Survival in Patients with Pancreatic Cancer
- 18 May 2018
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 22 (9) , 1565-1575
Revision of Surgical Margin under Frozen Section to Achieve R0 Status on Survival in Patients with Pancreatic Cancer
- 1 April 2017
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 265 (4) , e39-e41
Too Much Water Drowned the Miller—Does Extended Pancreaticoduodenectomy Benefit the Long-term Survival Outcomes in the Treatment of Pancreatic Cancer?
- 1 April 2017
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 265 (4) , e39-e41
Too Much Water Drowned the Miller—Does Extended Pancreaticoduodenectomy Benefit the Long-term Survival Outcomes in the Treatment of Pancreatic Cancer?
- 1 August 2015
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 262 (2) , e77-e78
Laparoscopic Retroperitoneal Hepatectomy for a Subcapsular Hepatocellular Carcinoma
- 1 August 2015
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 262 (2) , e77-e78
Laparoscopic Retroperitoneal Hepatectomy for a Subcapsular Hepatocellular Carcinoma
- 26 February 2015
- Published by Wiley in World Journal of Surgery
- Vol. 39 (7) , 1818-1827
Postoperative Complications Affect Long‐Term Survival Outcomes Following Hepatic Resection for Colorectal Liver Metastasis
Background: The impact of postoperative complications (POCs) on long‐term survival outcomes following hepatic resection for colorectal liver metastasis (CRLM) is in controversy. The aim of the present meta‐analysis was to systematically evaluate the POC effect on overall survival (OS) and disease‐free survival (DFS) in patients undergoing hepatic resection for CRLM.Methods: We conducted a systematic review and meta‐analysis of all observational studies to evaluate the POC effect on OS and DFS in patients undergoing hepatic resection for CRLM. A search for all major databases and relevant journals from inception to January 2014 without restriction on languages or regions was performed. POCs were extracted and graded according to a validated system of classification. Outcome measures were postoperative 1‐, 2‐, 3‐, and 10‐year OSs and DFSs. Both random‐effects and fixed‐effect models were used to pool the hazard ratios (HRs) of the survival outcomes. Test of heterogeneity was performed with the Q statistic.Results: A total of 2370 patients were included in the meta‐analysis. Both 5‐ and 10‐year postoperative OSs showed significant decreases in patients with POCs (HR = 1.52; 95 % CI 1.27–1.83; P < 0.001 and HR = 1.36; 95 % CI 1.18–1.58; P < 0.001, respectively). Similar outcomes were also observed in terms of DFSs, with the 5‐ and 10‐year HRs found to be 1.37 (95 % CI 1.23–1.53; P < 0.001) and 1.34 (95 % CI 1.17–1.53; P < 0.001), respectively, compared to no POC group.Conclusions: POCs are strongly related to long‐term oncologic outcomes following hepatic resection for CRLM. Further efforts to refine surgical technique and postoperative management to avoid complications may improve the long‐term oncological outcomes of the selected patients.
- 26 February 2015
- Published by Wiley in World Journal of Surgery
- Vol. 39 (7) , 1818-1827
Postoperative Complications Affect Long‐Term Survival Outcomes Following Hepatic Resection for Colorectal Liver Metastasis
Background: The impact of postoperative complications (POCs) on long‐term survival outcomes following hepatic resection for colorectal liver metastasis (CRLM) is in controversy. The aim of the present meta‐analysis was to systematically evaluate the POC effect on overall survival (OS) and disease‐free survival (DFS) in patients undergoing hepatic resection for CRLM.Methods: We conducted a systematic review and meta‐analysis of all observational studies to evaluate the POC effect on OS and DFS in patients undergoing hepatic resection for CRLM. A search for all major databases and relevant journals from inception to January 2014 without restriction on languages or regions was performed. POCs were extracted and graded according to a validated system of classification. Outcome measures were postoperative 1‐, 2‐, 3‐, and 10‐year OSs and DFSs. Both random‐effects and fixed‐effect models were used to pool the hazard ratios (HRs) of the survival outcomes. Test of heterogeneity was performed with the Q statistic.Results: A total of 2370 patients were included in the meta‐analysis. Both 5‐ and 10‐year postoperative OSs showed significant decreases in patients with POCs (HR = 1.52; 95 % CI 1.27–1.83; P < 0.001 and HR = 1.36; 95 % CI 1.18–1.58; P < 0.001, respectively). Similar outcomes were also observed in terms of DFSs, with the 5‐ and 10‐year HRs found to be 1.37 (95 % CI 1.23–1.53; P < 0.001) and 1.34 (95 % CI 1.17–1.53; P < 0.001), respectively, compared to no POC group.Conclusions: POCs are strongly related to long‐term oncologic outcomes following hepatic resection for CRLM. Further efforts to refine surgical technique and postoperative management to avoid complications may improve the long‐term oncological outcomes of the selected patients.